Home
|Insights
|The Long and Winding Road for BIOSIMILARS: Charting a Pathway through Patent, FDA, Antitrust, Prescription Filling, Reimbursement and Liability Law

PDF Link

The Long and Winding Road for BIOSIMILARS: Charting a Pathway through Patent, FDA, Antitrust, Prescription Filling, Reimbursement and Liability Law

Publication | 09.18.15

Contacts

Barbara H. Ryland
Senior Counsel
- Washington, D.C.
  - D | +1.202.624.2970
YnJ5bGFuZEBjcm93ZWxsLmNvbQ==

Insights

Publication | 09.03.25

Antitrust Risks in Responding To Tariffs

Publication | 08.27.25
False Claims Act Qui Tam Actions Won’t Doom Public Universities
Publication | 08.26.25
Court Of Federal Claims Decision Offers Potential Recovery Opportunity For Energy Savings Performance Contracts And Task Order Bid Protests
Publication | 08.22.25
Antitrust Probes of Classified Intel Require A Delicate Balance

View All Insights

Subscribe

to the latest insights from our team